AIM IMMUNOTECH
Live / Registered — Registered (as of 30 Jul 2024)
What this means for you
Registered since 30 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88604388
- Registration number
- 7463637
- Mark type
- Design + words
- Filed
- 04 Sept 2019
- Published for opposition
- 07 Jan 2020
- Registered
- 30 Jul 2024
- Attorney of record
- DONNA J. BUNTON
Goods and services
- Class 005 — Pharmaceuticals: Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
Owner
- AIM ImmunoTech Inc., Ocala, FL, US
- AIM ImmunoTech Inc., Ocala, FL, US
- AIM ImmunoTech Inc., Ocala, FL, US
Prosecution history
- 30 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jun 2024 — ASSIGNED TO LIE
- 09 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 09 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Aug 2023 — NON-FINAL ACTION E-MAILED
- 09 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 19 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE